5 research outputs found
Additional file 1 of Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
Additional file 1. Receiver operating characteristic curve for (Figure S1) ferritin level at baseline and (Figure S2) TSAT value at 1 month after the start of HIF-PH inhibitor treatment
IMT measurement, plaque area, and plaque gray scale median at each time point.
<p>IMT measurement, plaque area, and plaque gray scale median at each time point.</p
Baseline demographics and clinical characteristics.
<p>Baseline demographics and clinical characteristics.</p
Antidiabetic and other agents during the study.
<p>Antidiabetic and other agents during the study.</p